Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Impact of hospital volume on local recurrence and distant metastasis in bladder cancer patients treated with radical cystectomy in Sweden.

Sabir EF, Holmäng S, Liedberg F, Ljungberg B, Malmström PU, Månsson W, Wijkström H, Jahnson S.

Scand J Urol. 2013 Dec;47(6):483-90. doi: 10.3109/21681805.2013.787118.

PMID:
23590830
2.

Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.

Yu RJ, Stein JP, Cai J, Miranda G, Groshen S, Skinner DG.

J Urol. 2006 Aug;176(2):493-8; discussion 498-9.

PMID:
16813876
3.

Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.

Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, Lerner SP.

J Urol. 2006 Dec;176(6 Pt 1):2414-22; discussion 2422.

PMID:
17085118
5.

Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.

Lotan Y, Bagrodia A, Passoni N, Rachakonda V, Kapur P, Arriaga Y, Bolenz C, Margulis V, Raj GV, Sagalowsky AI, Shariat SF.

Eur Urol. 2013 Sep;64(3):465-71. doi: 10.1016/j.eururo.2013.03.043.

PMID:
23571005
6.

Predicting the survival of bladder carcinoma patients treated with radical cystectomy.

Cheng L, Weaver AL, Leibovich BC, Ramnani DM, Neumann RM, Scherer BG, Nehra A, Zincke H, Bostwick DG.

Cancer. 2000 May 15;88(10):2326-32.

PMID:
10820355
7.

Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy.

Madersbacher S, Hochreiter W, Burkhard F, Thalmann GN, Danuser H, Markwalder R, Studer UE.

J Clin Oncol. 2003 Feb 15;21(4):690-6.

PMID:
12586807
8.

Factors influencing post-recurrence survival in bladder cancer following radical cystectomy.

Mitra AP, Quinn DI, Dorff TB, Skinner EC, Schuckman AK, Miranda G, Gill IS, Daneshmand S.

BJU Int. 2012 Mar;109(6):846-54. doi: 10.1111/j.1464-410X.2011.10455.x.

9.

Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomy.

Horikawa Y, Kumazawa T, Narita S, Inoue T, Yuasa T, Matsuura S, Nanjo H, Satoh S, Tsuchiya N, Habuchi T.

Int J Clin Oncol. 2007 Apr;12(2):131-6.

PMID:
17443281
10.

Natural history of surgically treated bladder carcinoma with extravesical tumor extension.

Quek ML, Stein JP, Clark PE, Daneshmand S, Miranda G, Cai J, Groshen S, Lieskovsky G, Quinn DI, Raghavan D, Skinner DG.

Cancer. 2003 Sep 1;98(5):955-61.

11.
12.

[Analysis of 34 cases of infiltrating carcinoma of the bladder treated exclusively with partial cystectomy (part 1)].

Escudero Barrilero A, Fernández Fernández E, Jiménez Cidre M, Maganto Pavón E, Mayayo Dehesa T, Rodríguez Rodríguez R, Galvis San Juan F, Burgos Revilla FJ.

Arch Esp Urol. 1996 May;49(4):349-64. Review. Spanish.

PMID:
8754191
13.

Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.

Lotan Y, Gupta A, Shariat SF, Palapattu GS, Vazina A, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G, Perotte P, Schoenberg MP, Lerner SP, Sagalowsky AI.

J Clin Oncol. 2005 Sep 20;23(27):6533-9.

PMID:
16116151
14.
15.

Outcome after radical cystectomy with limited or extended pelvic lymph node dissection.

Dhar NB, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE.

J Urol. 2008 Mar;179(3):873-8; discussion 878. doi: 10.1016/j.juro.2007.10.076.

PMID:
18221953
16.

Oncologic outcomes and survival in pT0 tumors after radical cystectomy in patients without neoadjuvant chemotherapy: results from a large multicentre collaborative study.

Rouprêt M, Drouin SJ, Larré S, Neuzillet Y, Botto H, Hitier M, Rigaud J, Crew J, Xylinas E, Salomon L, Cornu JN, Iborra F, Champetier D, Rozet F, Flamand V, Bastide C, Cormier L, Durand X, Lunardi P, Rischmann P, Nouhaud FX, Ferlicot S, Patard JJ, Floch AP, Irani J, Peyronnet B, Bensalah K, Poissonnier L, Grès P, Droupy S, Casenave J, Wallerand H, Soulié M, Pfister C; Bladder Cancer Committee of the French National Association of Urology (“CC-AFU Vessie”)..

Ann Surg Oncol. 2011 Dec;18(13):3833-8. doi: 10.1245/s10434-011-1824-y.

PMID:
21647762
17.

Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy.

Bruins HM, Huang GJ, Cai J, Skinner DG, Stein JP, Penson DF.

J Urol. 2009 Nov;182(5):2182-7. doi: 10.1016/j.juro.2009.07.017.

PMID:
19758623
18.

Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival.

Bastian PJ, Hutterer GC, Shariat SF, Rogers CG, Palapattu GS, Lotan Y, Vazina A, Amiel GE, Gupta A, Sagalowsky AI, Lerner SP, Schoenberg MP, Karakiewicz PI; Bladder Cancer Research Consortium..

BJU Int. 2008 Feb;101(4):450-4.

19.

Prognostic significance of vascular invasion in patients with bladder cancer who underwent radical cystectomy.

Harada K, Sakai I, Hara I, Eto H, Miyake H.

Int J Urol. 2005 Mar;12(3):250-5.

20.

Local and systemic recurrence patterns of urothelial cancer after radical cystectomy.

Ozbir S, Girgin C, Kara C, Dinçel C.

Kaohsiung J Med Sci. 2014 Oct;30(10):504-9. doi: 10.1016/j.kjms.2014.03.011.

Supplemental Content

Support Center